Market Overview:
The global optical imaging system market is expected to exhibit a CAGR of 12.07% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
An optical imaging system utilizes photons of light to obtain detailed images of small structures, such as cells and molecules, in human, animal and plant tissues. It relies on non-ionizing radiation for reducing exposure to harmful radiation as compared to radiological imaging techniques. It can also be combined with other imaging techniques, such as magnetic resonance imaging (MRI) or X-rays, to provide enhanced information on complex diseases or experiments. Consequently, it finds extensive applications in genomics, proteomics, cell biology, and drug discovery and development.
www.imarcgroup.com
Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.
The optical imaging system is gaining traction as a real-time, sensitive and noninvasive modality for visualization, localization and measurement of bioactive molecules and molecular processes in vivo. It is also used as an essential tool for studying small-animal models and providing unique insights into disease pathogenesis, drug development and effects of therapy. Apart from this, researchers are using near-infrared (NIR) brain imaging to guide cerebral palsy treatment in pediatric patients. They are also developing miniature scanning laser microscopes to combine high-resolution images with wide-field color video images and improve early cancer diagnosis. The rising number of individuals suffering from cancer and the increasing geriatric population are further contributing to the market growth. Moreover, optical imaging is finding extensive applications in clinical diagnostics and preclinical research in various therapeutic areas, which is augmenting the growth of the market. Other factors, such as rising investments in research and development (R&D) activities, are anticipated to drive the market in the coming years.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global optical imaging system market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on technique, products, therapeutic area, application and end user.
Breakup by Technique:
www.imarcgroup.com
Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.
- Optical Coherence Tomography
- Hyperspectral Imaging
- Near-Infrared Spectroscopy
- Photoacoustic Tomography
- Others
Breakup by Products:
- Imaging System
- Software
- Lenses
- Illumination Systems
- Cameras
- Others
Breakup by Therapeutic Area:
- Neurology
- Oncology
- Ophthalmology
- Cardiology
- Dentistry
- Dermatology
- Others
Breakup by Application:
- Pre-clinical and Clinical Research
- Pathological Imaging
- Intra-operative Imaging
Breakup by End User:
- Hospitals and Clinics
- Research and Diagnostic Laboratories
- Pharmaceutical and Biotechnology Companies
Breakup by Region:
To get more information on the regional analysis of this market, Request Sample
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Bioptigen Inc. (Leica Microsystems), Canon Inc., Carl Zeiss Meditec AG, Headwall Photonics Inc., Heidelberg Engineering Inc., Koninklijke Philips, Optovue Inc., PerkinElmer Inc., St. Jude Medical Inc. and Topcon Corporation.
Report Coverage:
Report Features |
Details |
Base Year of the Analysis |
2021 |
Historical Period |
2016-2021 |
Forecast Period |
2022-2027 |
Units |
US$ Billion |
Segment Coverage |
Technique, Products, Therapeutic Area, Application, End User, Region |
Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered |
Abbott Laboratories, Bioptigen Inc. (Leica Microsystems), Canon Inc., Carl Zeiss Meditec AG, Headwall Photonics Inc., Heidelberg Engineering Inc., Koninklijke Philips, Optovue Inc., PerkinElmer Inc., St. Jude Medical Inc. and Topcon Corporation. |
Customization Scope |
10% Free Customization |
Report Price and Purchase Option |
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499 |
Post-Sale Analyst Support |
10-12 Weeks |
Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global optical imaging system market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global optical imaging system market?
- What are the key regional markets?
- What is the breakup of the market based on the technique?
- What is the breakup of the market based on the products?
- What is the breakup of the market based on the therapeutic area?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global optical imaging system market and who are the key players?
- What is the degree of competition in the industry?